GGrantIndex
← Search

DEFINING AND OVERCOMING A NOVEL EXTRACELLULAR MATRIX INHIBITOR OF REMYELINATION IN MS: FIBULIN-2

$740,715FY2022Defense Health AgencyDOD

Governors Of The University Of Calgary, The

Investigators

View source on USAspending →
DEFINING AND OVERCOMING A NOVEL EXTRACELLULAR MATRIX INHIBITOR OF REMYELINATION IN MS: FIBULIN-2 · GrantIndex